Filing Flows

Filing Flows › Companies › OSR Health › Cash flow

OSR Health cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$2.4M in Q2 2026 · −$7.2M over twelve months

Operating cash flow−$2.4M
Free cash flow−$2.4M

Analysis

In Q2 2026, OSR Health generated −$2.4M of operating cash flow. That is $1.9M less than in Q2 2025 (−$483K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$7.2M; the largest uses were operating cash flow ($7.2M), other investing ($3.4M); besides operations, cash came from other financing ($6.5M), net borrowing (+) / repaid (−) ($4.2M); the cash balance fell by $85K.

Operating cash flow was −$2.4M against net income of −$1.0M. The largest differences: depreciation & amortization +$2.4M, other liabilities −$2.3M, payables −$970K.

Free cash flow

OSR Health: free cash flow by quarterOSR Health: free cash flow by quarter−$686KQ3 2024−$181KQ4 2024−$64KQ1 2025−$483KQ2 2025−$2.7MQ3 2025−$1.1MQ4 2025−$1.0MQ1 2026−$2.4MQ2 2026
Operating cash flow less capital spending.
OSR Health: operating cash flow against capital spendingOSR Health: operating cash flow against capital spendingOperating cash flowCapital spending−$686K$0Q3 2024−$181K$0Q4 2024−$64K$0Q1 2025−$483K$0Q2 2025−$2.7M$0Q3 2025−$1.1M$0Q4 2025−$1.0M$0Q1 2026−$2.4M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$2.4M, Capital spending $0.

Capital allocation, year by year

OSR Health: where the cash came from (up) and went (down), by fiscal yearOSR Health: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesAcquisitionsBuybacksFY2021: Operating cash flow −$461FY2021FY2022: Operating cash flow −$4KFY2022FY2023: Operating cash flow −$819KFY2023: Net borrowing −$1.2MFY2023: Shares issued $9.2MFY2023: Buybacks −$36.0M$9.2MFY2023FY2024: Operating cash flow −$1.8MFY2024: Net borrowing $1.2MFY2024: Asset sales $6KFY2024: Buybacks −$36.2M$1.2MFY2024FY2025: Operating cash flow −$4.3MFY2025: Net borrowing $4.1MFY2025: Shares issued $4.8MFY2025: Asset sales $1KFY2025: Acquisitions $1.2M$10.1MFY2025
Over these 5 years operating cash flow totalled −$7.0M; the largest uses were buybacks ($72.2M) and operating cash flow ($7.0M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$1.5M
Debt$2.6M
Net debt$1.1M
Due within a year$2.4M
Cash runway2 months

OSR Health is burning cash: its operations consume cash, a free cash flow of −$7.2M a year at the current rate against $1.5M of cash and investments: a runway of about 2 months; $2.4M of debt also comes due within a year, which would need refinancing or new money before any new financing.

Where the cash came from and went

OSR Health: sources (+) and uses (−) of cash, Q2 2026OSR Health: sources (+) and uses (−) of cash, Q2 2026Operating cash flow−$2.4MShares issued$1.3MOther financing$988KNet borrowing (+) / repaid (−)$221KOther investing−$88KCash drawn (+) / kept (−)$67KExchange rates−$31KAcquisitions−$136
OSR Health: sources (+) and uses (−) of cash, TTM to Q2 2026OSR Health: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow−$7.2MOther financing$6.5MNet borrowing (+) / repaid (−)$4.2MOther investing−$3.4MExchange rates−$247KCash drawn (+) / kept (−)$85KAcquisitions$16KNot reconciled−$1

From profit to cash

OSR Health: net income to operating cash flow, Q2 2026OSR Health: net income to operating cash flow, Q2 2026Net income−$1.0MDepreciation & amortization$2.4MReceivables$60KInventory−$145KPayables−$970KAccrued liabilities−$32KPrepaid and other assets−$68KOther liabilities−$2.3MIncome taxes payable$11KOperating cash flow−$2.4M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowAcquisitionsBuybacksNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$2.4M−$136—$221K$1.3M$67K−$2.4M
Q1 2026−$1.0M$11K—$97K$845K$134K−$1.0M
Q4 2025−$1.1M−$8K—$1.8M$1.4M$477K−$1.1M
Q3 2025−$2.7M$13K—$736K—−$593K−$2.7M
Q2 2025−$483K$21K—$938K—$11K−$483K
Q1 2025−$64K$1.2M—$149K—−$1.3M−$64K
Q4 2024−$181K—−$19.2M$371K—$181K−$181K
Q3 2024−$686K——$338K—−$26K−$686K

OSR Health: income statement and cash flow

OSR Health, Q2 2026: revenue $316K (-72% year over year), operating margin -960.8%. The chart follows the revenue to costs, profit and cash.

OSR Health: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.